Pharmatek mentioned in article on Outsourcing-Pharma.com titled: Tech capabilities to offer CMOs advantages in stable oral dosage sector, report.

Author: Dan Stanton

Date: December 1, 2015

Click here to read the article.

 

Panel led by Pharmatek President, Tim Scott at Outsourced Pharma West discussing FDA Quality Metrics featured on OutsourcedPharma.com

Author: Louis Garguilo, Executive Editor, Outsourced Pharma

Date: November 10, 2015

Click here to read the article.

Pharmatek's Hot Rod Chemistry Kit featured in Neuroscience Journal

Authors: C. V. Fontanilla, X. Wei, L. Zhao, B. Johnstone, R. M. Pascuzzi,
M. R. Farlow,  &  Y. Du

Date: Neuroscience 205 (2012) Edition

Click here to read the article.

The Biocom CRO Group: Transforming San Diego’s Life Sciences Outsourcing Industry

Author: Tim Scott, President of Pharmatek

Date: BIOCOM Lifelines Magazine Spring 2015 Edition

Click here to read the article.

7 CEOs Say Outsourcing Advancing ... On Swirling Currents (Part 1)

Interview with: Tim Scott, President of Pharmatek

Date: March 3, 2015

Click here to read the article.

New Technologies Enhance the Formulation of Highly Potent Drugs

Interview with: Bryan Knox, Sr. Director of Pharmaceutics, Pharmatek

Date: October 2, 2014

Click here to read the article.

Unifying Theory Of Outsourcing From Pharmatek President

Interview with: Tim Scott, President of Pharmatek

Date: September 16, 2014

Click here to read the article.

Risk Assessment In Oral Drug Development

By: Bryan Knox, Sr. Director of Pharmaceutics, Pharmatek

Date: July 7, 2011

Summary:

Pharmatek’s Drug Development Risk Assessment Scorecard was designed to improve efficiency and reduce potential risk in drug development programs. The Scorecard is a quantitative approach to assessing risk in oral drug development programs with respect to Chemistry, Manufacturing, and Controls (CMC) activities. It is a tool created to help project managers identify drug program risks and provides them with a dashboard view of critical areas in the drug development process. Pharmatek’s Scorecard is based on evaluations of hundreds of different drug candidates, by Pharmatek scientists, over the last 12 years.

Click Here To Download a PDF of this White Paper

Have Questions For A Pharmatek Representative?

Contact Us